Russia may allow foreign COVID-19 vaccines onto domestic market

13 July 2021
russia_moscow_large-1-

The Russian government is considering allowing foreign vaccines against COVID-19 to enter the domestic market, according to recent statements by some senior state officials and some local media reports, reports The Pharma Letter’s local correspondent.

According to the Russian Health Minister Mikhail Murashko, so far, global manufacturers of anti-COVID-19 vaccines have already submitted applications for registration of their offerings on the Russian market.

According to analysts, the registration procedure itself takes an average of nine to 12 months, however, hypothetically, the authorities can agree to speed the procedure. While the head of the Ministry of Health did not specify what vaccines could be allowed, some companies, such as Johnson & Johnson (NYSE: JNJ), said they are ready to supply their vaccine to Russia.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK

Companies featured in this story

More ones to watch >


Today's issue

Company Spotlight





More Features in Biotechnology